Published in J Biomater Sci Polym Ed on January 01, 1998
Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev (2008) 2.63
Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev (2011) 1.35
Synthesis of poly(propylene fumarate). Nat Protoc (2009) 1.20
Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter (2010) 1.15
Synthesis of oligo(poly(ethylene glycol) fumarate). Nat Protoc (2012) 1.09
2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. AIChE J (2008) 0.82
Founder's award to Antonios G. Mikos, Ph.D., 2011 Society for Biomaterials annual meeting and exposition, Orlando, Florida, April 13-16, 2011: Bones to biomaterials and back again--20 years of taking cues from nature to engineer synthetic polymer scaffolds. J Biomed Mater Res A (2011) 0.79
Poly(ethylene glycol) hydrogels with adaptable mechanical and degradation properties for use in biomedical applications. Macromol Biosci (2014) 0.77
PLGA bone plates reinforced with crosslinked PPF. J Mater Sci Mater Med (2002) 0.75
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Review: tissue engineering for regeneration of articular cartilage. Biomaterials (2000) 2.40
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
General strategies for nanoparticle dispersion. Science (2006) 1.96
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
"Blastokinin": inducer and regulator of blastocyst development in the rabbit uterus. Science (1967) 1.11
Growing new organs. Sci Am (1999) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Ascorbic acid dynamics in the seriously ill and injured. J Surg Res (2003) 1.07
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. J Biomater Sci Polym Ed (1995) 1.07
Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed (2006) 1.06
Bone tissue engineering. Nat Med (1995) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A (2009) 1.05
Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials (1999) 1.05
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1999) 1.04
Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials (1999) 1.03
Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed (1999) 1.01
Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res (1994) 1.00
Recent progress in gene delivery using non-viral transfer complexes. J Control Release (2001) 1.00
Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant (1997) 0.99
Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng (2000) 0.99
In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98
Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res (2000) 0.97
TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am (2001) 0.97
Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res (1997) 0.97
Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J Biomed Mater Res (1997) 0.95
Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater (2010) 0.94
Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release. Biomaterials (1995) 0.93
Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng (1999) 0.92
Characterization of partially saturated poly(propylene fumarate) for orthopaedic application. J Biomater Sci Polym Ed (1997) 0.92
Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res (2000) 0.91
Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials (2001) 0.91
Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behavior. Eur Cell Mater (2011) 0.90
Degradation and biocompatibility of a poly(propylene fumarate)-based/alumoxane nanocomposite for bone tissue engineering. J Biomed Mater Res A (2007) 0.90
Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A (2008) 0.90
Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant (1999) 0.89
Modulation of marrow stromal cell function using poly(D,L-lactic acid)-block-poly(ethylene glycol)-monomethyl ether surfaces. J Biomed Mater Res (1999) 0.89
Biodegradable fumarate-based drug-delivery systems for ophthalmic applications. J Biomed Mater Res A (2009) 0.89
Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater (2011) 0.88
In vitro and in vivo degradation of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1998) 0.87
Poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers control adhesion and osteoblastic differentiation of marrow stromal cells. Tissue Eng (2003) 0.87
Retinal pigment epithelial cell adhesion on novel micropatterned surfaces fabricated from synthetic biodegradable polymers. Biomaterials (2001) 0.86
In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres. Acta Biomater (2009) 0.85
Integrin alpha(v)beta(3) is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor. J Cell Biochem (2001) 0.85
Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1997) 0.83
Preparation of macroporous poly(2-hydroxyethyl methacrylate) hydrogels by enhanced phase separation. Biomaterials (2000) 0.83
Isolated patch of speckled, congenital, pigmented dermal melanocytosis outside the face or acromioclavicular regions. J Eur Acad Dermatol Venereol (2003) 0.83
Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop Relat Res (1999) 0.82
Osseointegration of preformed polymethylmethacrylate craniofacial prostheses coated with bone marrow-impregnated poly (DL-lactic-co-glycolic acid) foam. Plast Reconstr Surg (1999) 0.82
Cell seeding in porous transplantation devices. Biomaterials (1993) 0.82
Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers. J Control Release (2006) 0.80
Studies on the relationship between uterine fluid components and the diapausing state of blastocysts from mammals having delayed implantation. J Exp Zool (1969) 0.80
Retinal pigment epithelial cell function on substrates with chemically micropatterned surfaces. Biomaterials (1999) 0.80
Guided bone growth in sheep: a model for tissue-engineered bone flaps. Tissue Eng (1996) 0.80
PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym Ed (2008) 0.80
Effect of macromer molecular weight on in vitro ophthalmic drug release from photo-crosslinked matrices. Acta Biomater (2007) 0.79
Intra-articular microparticles for drug delivery to the TMJ. J Dent Res (2010) 0.79
Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro. Biomaterials (1998) 0.79
Brain gangliosides of several species. Anal Biochem (1968) 0.79
Preventing Pyxis wars: without nurses, inventory control impossible. Hosp Mater Manage (1999) 0.79
Retinal pigment epithelium cell culture on thin biodegradable poly(DL-lactic-co-glycolic acid) films. J Biomater Sci Polym Ed (1998) 0.78
Composition of "blastokinin" from rabbit uterus. Biochim Biophys Acta (1968) 0.78
Amino acid requirements for growth of the rabbit blastocyst in vitro. J Cell Physiol (1967) 0.78
An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2. J Cell Biochem (2001) 0.77